Replies to post #369624 on Amarin Corp Plc (AMRN)

[ggwpq]

marjac, you are right with your argument. However, I would not underestimate some judges' disdain towards greedy pharma companies (i.e. Amarin) and their high regard towards generic companies (i.e., Hikma/Dr. Reddy's) for their roles in saving our healthcare system (which we know is not true). To the panel, GV is just as effective as V but cheaper.

Thanks for all you have done which can't be expressed by words alone. Therefore, I'll pick up the tab in your favorite restaurant at Great Neck, NY, for our victory celebration.

[roadkilll]

The ICER report stating Vascepa is a very cost effective drug that will lower health care cost for the public. Badly needs marketing to a Covid distracted medical field.

I'm 100% in favor of generics sticking to their skinny label. Can someone show me 10 competent medical practitioners that would write a Vascepa script without a CV benefit intended? Most obvious abuse of the skinny label I think you can find and it was created by a Judge Du. Does she have any responsibility in reviewing her patent decision and the "unintended" consequences.